BIOATLA, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
BIOATLA, INC. (BCAB) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $12.52 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-31
- BIOATLA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $12.52M, a 14.57% decline from fiscal 2024.
- BIOATLA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $14.65M.
- BIOATLA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$25.93M.
- BIOATLA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$22.36M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $12.52M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $14.65M 10-K · filed 2026-03-31 | -$14.65M 10-K · filed 2025-03-28 |
| 2023-12-31 | -$25.93M 10-K · filed 2025-03-28 | |
| 2022-12-31 | -$22.36M 10-K · filed 2024-03-26 | |
| 2021-12-31 | -$20.03M 10-K · filed 2023-03-23 | |
| 2020-12-31 | -$7.53M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |